Globus Medical Inc.
GMED | NYSE
$79.45
+$1.40 (+1.79%)
At close: Nov 2, 2026, 3:59 PM ET
$78.21
+$0.16 (+0.20%)
Pre-market:
Nov 2, 2026, 9:07 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.14B | 3.1B | 2.94B | 2.77B | 2.63B | 2.51B | 2.52B | 2.48B | 2.24B | 1.9B | 1.57B | 1.23B | 1.1B | 1.07B | 1.02B | 998.37M | 973.94M | 961.31M | 958.1M | 941.53M | 927.9M | 825.81M |
Cost of Revenue | 989.14M | 996.47M | 957.8M | 989.98M | 978.11M | 989.39M | 1.04B | 1.04B | 902.4M | 718.84M | 548.17M | 353.28M | 283.39M | 275.38M | 263.73M | 254.93M | 247.99M | 243.36M | 239.22M | 238.29M | 236.83M | 223.63M |
Gross Profit | 2.16B | 2.1B | 1.98B | 1.78B | 1.65B | 1.52B | 1.48B | 1.44B | 1.33B | 1.18B | 1.02B | 873.16M | 813.56M | 793.6M | 759.12M | 743.44M | 725.95M | 717.94M | 718.88M | 703.24M | 691.07M | 602.18M |
Operating Income | 652.69M | 546.37M | 479.8M | 368.4M | 281.49M | 255M | 165.99M | 115.84M | 68.15M | 84.74M | 133.14M | 177.05M | 236.35M | 237.91M | 227.95M | 192.12M | 185.75M | 163.85M | 171.95M | 212.29M | 208.97M | 137.53M |
Interest Income | 10.2M | 10.89M | 7.14M | 3.83M | 2.37M | 1.68M | n/a | n/a | 7.92M | 7.92M | 7.92M | 7.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 664.95M | 663.31M | 609.9M | 460.5M | 373.54M | 232.95M | 120.72M | 121.05M | 66.55M | 93.65M | 165.39M | 202.51M | 261.44M | 257.31M | 243.02M | 200.73M | 193.72M | 172.11M | 180.41M | 222.79M | 221.47M | 150.6M |
Net Income | 535.46M | 586.74M | 537.9M | 423.78M | 356.65M | 185.56M | 102.98M | 91.51M | 40.68M | 66.63M | 122.87M | 157.9M | 204.34M | 201.22M | 190.17M | 155.21M | 154.99M | 141.95M | 149.19M | 187.04M | 184.05M | 121.67M |
Selling & General & Admin | 1.35B | 1.37B | 1.32B | 1.11B | 1.04B | 976.47M | 982.35M | 973.59M | 889.06M | 769.67M | 643.41M | 516.77M | 467.14M | 453.79M | 432.12M | 420.6M | 410.47M | 411.01M | 408.15M | 393.64M | 386.34M | 359.11M |
Research & Development | 184.82M | 188.45M | 185M | 144.49M | 141.8M | 139.55M | 163.75M | 182.6M | 176.55M | 160.2M | 124.01M | 91.27M | 80.64M | 76.69M | 73.02M | 104.53M | 101.68M | 99.83M | 97.35M | 61.57M | 60.13M | 84.04M |
Other Expenses | -34.63M | -333K | n/a | 153.44M | 184.42M | 150.4M | 171.78M | 169.04M | 200.38M | 165.01M | 119.74M | 88.08M | 29.45M | 25.22M | 26.04M | 26.18M | 28.05M | 43.25M | 41.43M | 35.75M | 35.63M | 21.5M |
Operating Expenses | 1.5B | 1.56B | 1.5B | 1.41B | 1.37B | 1.27B | 1.32B | 1.33B | 1.27B | 1.09B | 887.16M | 696.11M | 577.22M | 555.69M | 531.17M | 551.31M | 540.2M | 554.09M | 546.93M | 490.95M | 482.1M | 464.65M |
Interest Expense | n/a | n/a | n/a | 815K | 1.59M | 3.93M | 5.82M | 7.59M | 6.81M | 12.77M | 17.37M | 20.11M | 24.01M | 18.19M | 14.23M | 10.86M | 9.06M | 9.13M | 9.3M | 10.31M | 11.29M | 12.34M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.49B | 2.55B | 2.46B | 2.4B | 2.34B | 2.26B | 2.35B | 2.36B | 2.17B | 1.81B | 1.44B | 1.05B | 860.6M | 831.07M | 794.89M | 806.24M | 788.19M | 797.46M | 786.15M | 729.24M | 718.93M | 688.28M |
Income Tax Expense | 129.49M | 76.57M | 72M | 36.72M | 16.89M | 47.39M | 17.74M | 29.54M | 25.88M | 27.02M | 42.52M | 44.61M | 57.11M | 56.1M | 52.85M | 45.52M | 38.73M | 30.17M | 31.22M | 35.75M | 37.42M | 28.93M |
Shares Outstanding (Basic) | 135.36M | 135.36M | 135.15M | 134.5M | 135.21M | 136.76M | 136.73M | 135.62M | 135.2M | 135.36M | 137.88M | 113.54M | 100.37M | 100.28M | 99.97M | 99.65M | 100.67M | 101.6M | 101.5M | 101.1M | 100.45M | 99.87M |
Shares Outstanding (Diluted) | 138.19M | 138.19M | 137.22M | 135.39M | 136.5M | 139.77M | 139.71M | 138.06M | 136.98M | 135.36M | 139.02M | 115.25M | 101.78M | 102.2M | 102.21M | 101.42M | 102.88M | 104.08M | 104.19M | 104.42M | 103.48M | 102.42M |
EPS (Basic) | 3.97 | 4.35 | 3.98 | 3.12 | 2.62 | 1.35 | 0.75 | 0.67 | 0.30 | 0.64 | 1.18 | 1.57 | 2.04 | 2.01 | 1.89 | 1.54 | 1.53 | 1.40 | 1.48 | 1.87 | 1.85 | 1.23 |
EPS (Diluted) | 3.89 | 4.28 | 3.92 | 3.10 | 2.60 | 1.34 | 0.75 | 0.67 | 0.30 | 0.64 | 1.17 | 1.55 | 2.01 | 1.97 | 1.86 | 1.51 | 1.49 | 1.36 | 1.43 | 1.81 | 1.80 | 1.19 |
EBITDA | 876.26M | 879.89M | 817.09M | 717.98M | 618.8M | 551.74M | 472.42M | 424.25M | 394.65M | 355.53M | 346.58M | 328.2M | 318.48M | 314.83M | 304.5M | 268.69M | 263.11M | 258.39M | 264.73M | 299.22M | 295.75M | 206.67M |
EBIT | 664.95M | 597.95M | 538.93M | 441.92M | 346.92M | 286.9M | 218.4M | 167.3M | 167.25M | 173.64M | 201.85M | 237.72M | 247.81M | 245.31M | 236.25M | 200.52M | 195.77M | 188.84M | 194.86M | 229.28M | 226.26M | 141.2M |
Depreciation & Amortization | 211.31M | 281.94M | 278.16M | 276.06M | 271.88M | 264.84M | 254.02M | 256.96M | 227.4M | 181.89M | 144.73M | 90.48M | 70.67M | 69.52M | 68.25M | 68.17M | 67.34M | 69.55M | 69.87M | 69.94M | 69.49M | 65.46M |
Add to Watchlist
Select watchlists to add or remove GMED